Both Ledue et al. [68] and Pegalajar-Jurado et al. [29] observed that the sensitivity of the Oxford Immunotec C6 IgG/IgM EIA appeared equivalent to the Liaison® VlsE-IgG/IgM chemiluminescent assay for early neurological disease. The gene discussed is CD40LG; the disease is nervous system disorder.